Outlook Therapeutics Inc (OTLK)
8.51
-0.41
(-4.60%)
USD |
NASDAQ |
May 01, 16:00
8.51
0.00 (0.00%)
After-Hours: 18:27
Outlook Therapeutics 1 Year Total Returns (Daily): -57.52% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 30, 2024 | -57.52% |
April 29, 2024 | -56.67% |
April 26, 2024 | -60.97% |
April 25, 2024 | -62.43% |
April 24, 2024 | -62.39% |
April 23, 2024 | -64.96% |
April 22, 2024 | -65.43% |
April 19, 2024 | -64.48% |
April 18, 2024 | -61.97% |
April 17, 2024 | -60.14% |
April 16, 2024 | -59.49% |
April 15, 2024 | -60.09% |
April 12, 2024 | -58.57% |
April 11, 2024 | -57.36% |
April 10, 2024 | -56.78% |
April 09, 2024 | -55.05% |
April 08, 2024 | -54.61% |
April 05, 2024 | -54.61% |
April 04, 2024 | -53.33% |
April 03, 2024 | -57.38% |
April 02, 2024 | -55.50% |
April 01, 2024 | -52.94% |
March 28, 2024 | -40.30% |
March 27, 2024 | -53.61% |
March 26, 2024 | -57.86% |
Date | Value |
---|---|
March 25, 2024 | -58.69% |
March 22, 2024 | -58.11% |
March 21, 2024 | -67.41% |
March 20, 2024 | -67.09% |
March 19, 2024 | -62.98% |
March 18, 2024 | -61.08% |
March 15, 2024 | -59.21% |
March 14, 2024 | -72.18% |
March 13, 2024 | -68.93% |
March 12, 2024 | -65.39% |
March 11, 2024 | -61.30% |
March 08, 2024 | -63.74% |
March 07, 2024 | -64.23% |
March 06, 2024 | -64.16% |
March 05, 2024 | -64.66% |
March 04, 2024 | -62.27% |
March 01, 2024 | -62.38% |
February 29, 2024 | -59.93% |
February 28, 2024 | -59.86% |
February 27, 2024 | -59.74% |
February 26, 2024 | -60.70% |
February 23, 2024 | -62.35% |
February 22, 2024 | -63.01% |
February 21, 2024 | -63.97% |
February 20, 2024 | -60.91% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.12%
Minimum
Mar 24 2020
357.4%
Maximum
Mar 19 2021
-6.55%
Average
-41.03%
Median
Jul 30 2020
1 Year Total Returns (Daily) Benchmarks
Cutera Inc | -89.39% |
Actinium Pharmaceuticals Inc | -12.50% |
GT Biopharma Inc | -73.70% |
Karyopharm Therapeutics Inc | -71.23% |
Marinus Pharmaceuticals Inc | -84.56% |